Literature DB >> 24726071

Strategically investing in health research: the little-big program called RPP.

Penny Moody-Corbett1.   

Abstract

The Regional Partnerships Program (RPP) was a program of the Canadian Institutes of Health Research (CIHR) and six provinces - Saskatchewan, Manitoba, New Brunswick, Nova Scotia, Prince Edward Island, and Newfoundland and Labrador. CIHR and each province contributed 50% to support health research that was recommended for funding by peer review but fell below the CIHR budgetary cut-off for funding. The provinces would like to commend CIHR for this strategic initiative and highlight the impact that small investment like RPP has had on engaging these provinces in the health research enterprise and expanding health research and its benefits across the country.
Copyright © 2014 Longwoods Publishing.

Entities:  

Mesh:

Year:  2014        PMID: 24726071      PMCID: PMC3999570     

Source DB:  PubMed          Journal:  Healthc Policy        ISSN: 1715-6572


  2 in total

1.  Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.

Authors:  Nancy D Merner; Kathy A Hodgkinson; Annika F M Haywood; Sean Connors; Vanessa M French; Jörg-Detlef Drenckhahn; Christine Kupprion; Kalina Ramadanova; Ludwig Thierfelder; William McKenna; Barry Gallagher; Lynn Morris-Larkin; Anne S Bassett; Patrick S Parfrey; Terry-Lynn Young
Journal:  Am J Hum Genet       Date:  2008-02-28       Impact factor: 11.025

2.  Translation of research discoveries to clinical care in arrhythmogenic right ventricular cardiomyopathy in Newfoundland and Labrador: lessons for health policy in genetic disease.

Authors:  Kathy Hodgkinson; Elizabeth Dicks; Sean Connors; Terry-Lynn Young; Patrick Parfrey; Daryl Pullman
Journal:  Genet Med       Date:  2009-12       Impact factor: 8.822

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.